License: Creative Commons License Open Access by Alzheimers & Parkinsons Disease: Open Access is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at SciRes Literature..

Manuscript should be submitted in Word Document (.doc or .docx) through online form or can be mailed to the particular journal's E-mail ID or to submit@scireslit.com, scireslit@gmail.com

Review Articles

Articles

We publish a wide range of article types in the Medical and Clinical Groups.

Our Vision

SciRes Literature main aim is to enhance the importance of science and technology to the scientific community and also to provide an equal opportunity to seek and share ideas to all our researchers and scientists without any barriers to develop their career and helping in their development of discovering the world.

Author Feedback

Hsien-Yuan Lane

Hsien-Yuan Lane

China Medical University, Taiwan

Hsien-Yuan Lane, M.D.,Ph.D. is the Director and Professor of Department of Psychiatry and Institute of Clinical Medical Science at China Medical University Medical College, Taichung, Taiwan. He has been devoted to translational studies and clinical trials, especially those on several NMDA-enhancing agents for treatment of various mental disorders. His team is the first group to demonstrate the therapeutic efficacy of glycine transporter I inhibitor in patients with schizophrenia, setting the tone of these lines of novel treatments. 
Hsien-Yuan Lane, M.D.,Ph.D. is the Director and Professor of Department of Psychiatry and Institute of Clinical Medical Science at China Medical University Medical College, Taichung, Taiwan. He has been devoted to translational studies and clinical trials, especially those on several NMDA-enhancing agents for treatment of various mental disorders. His team is the first group to demonstrate the therapeutic efficacy of glycine transporter I inhibitor in patients with schizophrenia, setting the tone of these lines of novel treatments. 
 
Hsien-Yuan Lane, M.D.,Ph.D. is the Director and Professor of Department of Psychiatry and Institute of Clinical Medical Science at China Medical University Medical College, Taichung, Taiwan. He has been devoted to translational studies and clinical trials, especially those on several NMDA-enhancing agents for treatment of various mental disorders. His team is the first group to demonstrate the therapeutic efficacy of glycine transporter I inhibitor in patients with schizophrenia, setting the tone of these lines of novel treatments. 
Hsien-Yuan Lane, M.D.,Ph.D. is the Director and Professor of Department of Psychiatry and Institute of Clinical Medical Science at China Medical University Medical College, Taichung, Taiwan. He has been devoted to translational studies and clinical trials, especially those on several NMDA-enhancing agents for treatment of various mental disorders. His team is the first group to demonstrate the therapeutic efficacy of glycine transporter I inhibitor in patients with schizophrenia, setting the tone of these lines of novel treatments. 
Hsien-Yuan Lane, M.D.,Ph.D. is the Director and Professor of Department of Psychiatry and Institute of Clinical Medical Science at China Medical University Medical College, Taichung, Taiwan. He has been devoted to translational studies and clinical trials, especially those on several NMDA-enhancing agents for treatment of various mental disorders. His team is the first group to demonstrate the therapeutic efficacy of glycine transporter I inhibitor in patients with schizophrenia, setting the tone of these lines of novel treatments. 

 

  Authors submit all Proposals and manuscripts via Electronic Form! Submit a Manuscript!